Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1062
http://purl.obolibrary.org/obo/NCIT_C1062
|
|---|---|
| Preferred Name | Duborimycin |
| Definitions |
An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Duborimycin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Duborimycin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis. (NCI04) |
|---|---|
| prefLabel | Duborimycin
|
| label | Duborimycin
|
| PDQ_Closed_Trial_Search_ID | 39228
|
| code | C1062
|
| prefixIRI | NCIT:C1062
|
| in_subset | |
| Preferred_Name | Duborimycin
|
| FDA_UNII_Code | YDU8YIP30L
|
| Contributing_Source | FDA
|
| Maps_To | Duborimycin
|
| CAS_Registry | 28008-55-1
|
| NSC Number | 180510
|
| NCI_Drug_Dictionary_ID | 39228
|
| Legacy Concept Name | Duborimycin
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 39228
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
Antibiotic
|
| UMLS_CUI | C0057159
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |